Glucarpidase Should Not Be Administered Until At Least 2 Hours After Leucovorin
The recommended time gap is a minimum of 2 hours between leucovorin and glucarpidase administration 1, 2. This timing is critical because both drugs interact with folate pathways, and concurrent administration may reduce the effectiveness of glucarpidase.
Rationale for the 2-Hour Gap
Glucarpidase is a bacterial enzyme that rapidly cleaves methotrexate into inactive metabolites, but it also has affinity for folate analogues including leucovorin 2, 3. When leucovorin is present in the bloodstream during glucarpidase administration, the enzyme can degrade leucovorin along with methotrexate, potentially reducing the protective effect of leucovorin rescue 3, 4.
Practical Administration Guidelines
Before Glucarpidase:
- Administer leucovorin at least 2 hours before glucarpidase 2
- Continue the same leucovorin dose that was being given prior to glucarpidase
After Glucarpidase:
- Wait at least 2 hours after glucarpidase before resuming leucovorin 2
- For the first 48 hours post-glucarpidase, continue the same leucovorin dose used before glucarpidase 2
- After 48 hours, adjust leucovorin dosing based on measured methotrexate concentrations using chromatographic methods (not immunoassays, which are unreliable within 48 hours of glucarpidase) 2
Important Caveats
Timing is critical for glucarpidase efficacy: The drug should ideally be administered within 48-60 hours from the start of high-dose methotrexate infusion 3, 5. Delayed administration beyond 96 hours is associated with increased mortality and severe toxicity 3, 5. Early recognition of delayed methotrexate elimination and rapid intervention are essential for optimal outcomes 6.
Recent evidence suggests that concurrent leucovorin may not significantly compromise glucarpidase's ability to metabolize methotrexate 4, but the 2-hour separation remains the FDA-approved recommendation to ensure maximum efficacy of both agents 2.
Continue leucovorin until methotrexate concentration remains below the leucovorin treatment threshold for a minimum of 3 consecutive days 2.